Periodic Reporting for period 1 - RoNDBioCan (NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway)

The identification of new therapeutic strategies in the treatment of lung cancer is a research priority. Today 40% of these cancers remain of undetermined origin, so there is a crucial need to identify new mechanisms behind lung cancer. The action of current therapies relies...